Evaluation of the PPAR-? Agonist Pioglitazone in Mild Asthma: A Double-Blind Randomized Controlled Trial. (2016)
Attributed to:
Nottingham Molecular Pathology Node (NMPN) for Integrated Multi-platform Biomarker Research and Knowledge Transfer
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1371/journal.pone.0160257
PubMed Identifier: 27560168
Publication URI: http://europepmc.org/abstract/MED/27560168
Type: Journal Article/Review
Volume: 11
Parent Publication: PloS one
Issue: 8
ISSN: 1932-6203